Aphria Inc.'s Chief Executive Officer Vic Neufeld and Co-founder Cole Cacciavillani are both nearing the end of their five-year journey with the company and will transition out of their executive roles over the coming months but remain on the Board. Working closely with Irwin D. Simon, Aphria's recently appointed independent Chair, and President Jakob Ripshtein, Mr. Neufeld and Mr. Cacciavillani intend to complete a smooth and responsible transition to a globally minded executive leadership team for the long-term benefit of the company's patients, shareholders, customers, and employees. The board has requested that, following the transition, Mr. Neufeld and Mr. Cacciavillani continue to apply their knowledge and expertise as special advisors to both the Chair and the President, ensuring a smooth transition of institutional experience and strategic advice until a new CEO is appointed.